Education
About Us
Working with TipRanks
Follow Us
PaxMedica, Inc. (PXMD)
OTHER OTC:PXMD
PXMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.03 - $0.32
Previous CloseN/A
Volume26.44K
Average Volume (3M)37.62K
Market Cap
$1.09K
Enterprise Value$836.04M
Total Cash (Recent Filing)$324.49K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta22.65
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.88
Shares Outstanding10,879,170
10 Day Avg. Volume1,549
30 Day Avg. Volume37,622
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)-8.51K
Price to Sales (P/S)0.00
P/FCF Ratio-1.99K
Enterprise Value/Market Cap768.42K
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-11.67
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
PaxMedica, Inc. News
PremiumCompany Announcements
PaxMedica Renames to Kuvatris, Cancels Shares
PremiumCompany Announcements
PaxMedica Announces Board Chairman Resignation Amid Transition
PremiumCompany Announcements
PaxMedica Announces Resignation of Key Executives
Options Prices
Currently, No data available
---
Ownership Overview
0.65% Insiders
―
Mutual Funds
0.71% Other Institutional Investors
99.29% Public Companies and
Individual Investors
PXMD FAQ
What was PaxMedica, Inc.’s price range in the past 12 months?
PaxMedica, Inc. lowest stock price was $0.03 and its highest was $0.32 in the past 12 months.
What is PaxMedica, Inc.’s market cap?
PaxMedica, Inc.’s market cap is $1.09K.
When is PaxMedica, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were PaxMedica, Inc.’s earnings last quarter?
Currently, no data Available
Is PaxMedica, Inc. overvalued?
According to Wall Street analysts PaxMedica, Inc.’s price is currently Overvalued.
Does PaxMedica, Inc. pay dividends?
PaxMedica, Inc. does not currently pay dividends.
What is PaxMedica, Inc.’s EPS estimate?
PaxMedica, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PaxMedica, Inc. have?
PaxMedica, Inc. has 10,879,170 shares outstanding.
What happened to PaxMedica, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of PaxMedica, Inc.?
Currently, no hedge funds are holding shares in PXMD
Company Description
PaxMedica, Inc.
PaxMedica, Inc. (PXMD) is a clinical-stage biopharmaceutical company focused on developing innovative therapies to address unmet needs in the field of neurodevelopmental disorders and other central nervous system conditions. The company's primary focus is on the development and commercialization of novel treatments, with its lead product candidate aimed at treating autism spectrum disorder (ASD) and other related conditions.
Technical Analysis
MannKind
―
Neurocrine
―
Anavex Life Sciences
―
Bioxcel Therapeutics
―
Shuttle Pharmaceuticals Holdings, Inc.
―